GlassScriptPhysician profile
John S Liu
NPI 1467431403
$8,005.80
in general payments reported to CMS, 2019-2025
38 companies · $395 in 2025
The $395 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,072 · 2020: $627 · 2021: $282 · 2022: $665 · 2023: $1,838 · 2024: $1,127 · 2025: $395.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,025 · Travel and Lodging: $1,210 · Grant: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,025.26 |
| Travel and Lodging | $1,210.24 |
| Grant | $125.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Palette Life Sciences, INC. | $2,175.74 | 2021-2023 | |
| Neotract INC. | $1,416.20 | 2019-2020 | |
| Teleflex LLC | $716.49 | 2021-2025 | Urolift, Barrigel |
| Janssen Biotech, INC. | $381.17 | 2019-2024 | Erleada, Akeega |
| Procept Biorobotics Corporation | $326.71 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Dendreon Pharmaceuticals LLC | $294.03 | 2019-2020 | |
| Astellas Pharma US INC | $275.52 | 2019-2020 | |
| Bioprotect Medical, INC. | $211.60 | 2024-2025 | Bioprotect Balloon Implant System |
| Boston Scientific Corporation | $204.88 | 2019-2025 | Spaceoar Vue System - 10ml |
| Travere Therapeutics, INC. | $176.20 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $170.93 | 2019-2020 | |
| Richard Wolf Medical Instruments Corp. | $145.85 | 2019 | |
| Abbvie INC. | $143.52 | 2019-2024 | |
| Coloplast Corp | $129.61 | 2019-2020 | |
| Calyxo, INC. | $124.67 | 2024-2025 | Cvac Aspiration System |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $113.04 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $106.87 | 2019-2025 | |
| Blue Earth Diagnostics | $104.01 | 2019-2024 | |
| Urogen Pharma, INC. | $102.40 | 2021 | |
| Acell, INC. | $101.28 | 2019-2020 | |
| Antares Pharma, INC. | $75.47 | 2019-2020 | |
| Innovation Technologies INC | $69.62 | 2024 | Irrisept |
| Amgen INC. | $50.25 | 2019 | |
| Olympus America INC. | $47.82 | 2019-2020 | |
| Zyla Life Sciences, INC. | $47.66 | 2019 | |
| Allergan, INC. | $40.75 | 2019 | |
| Novartis Pharmaceuticals Corporation | $38.98 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $30.84 | 2019 | |
| Karyopharm Therapeutics INC. | $30.37 | 2020 | |
| Tolmar Pharmaceuticals, INC. | $28.45 | 2019-2020 | |
| Karl Storz Endoscopy-America | $28.13 | 2025 | N.A. |
| Pfizer INC. | $27.85 | 2024 | |
| Cook Medical LLC | $18.30 | 2024 | Litho 150 |
| Abbott Laboratories | $17.95 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $17.16 | 2020 | |
| Dentsply Ih INC. | $15.48 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$637,739.29 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.